Filing Details
- Accession Number:
- 0001209191-18-009625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-13 17:02:18
- Reporting Period:
- 2018-02-13
- Accepted Time:
- 2018-02-13 17:02:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1590750 | Miragen Therapeutics Inc. | MGEN | Services-Medical Laboratories (8071) | 471187261 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1693134 | Scott Adam Levy | C/O Miragen Therapeutics, Inc. 6200 Lookout Road Boulder CO 80301 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-02-13 | 9,090 | $5.50 | 10,540 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents shares purchased through the Issuer's follow-on public offering.